U.S. President Joe Biden will call for a nationwide cap of $35 a month on out-of-pocket insulin costs during his State of the Union Address on Tuesday, but is unlikely to get his wish as it lacks enough Congressional support.
https://www.pharmalive.com/wp-content/uploads/2021/12/Drugmakers-aim-big-price-hikes-at-U.S.-patients-–-congressional-report-Reuters-12-10-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-02-07 19:33:022023-02-08 10:13:36Biden to push for insulin cost caps, but unlikely to secure Congressional approval
